Cost and burden of poor control of the level of anticoagulation in patients with non-valvular atrial fibrillation treated with vitamin K antagonist in the Spanish National Health Service
Event: ESC Congress 2019
Topic: Health Economics
Session: Costs in different public health settings
ESC 365 is supported by
